Mineralys Therapeutics Inc (MLYS)
$18.18 -14.41% Close Oct 30, 2026 Live
Mineralys Therapeutics stock today
Mineralys Therapeutics closed at $18.18 on October 30, 2026, down 14.41% on the day. Over the past year it returned -55.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.50 billion.
$20.00$30.00$40.00
NovJan 2026MarMayJulSep
| Period | MLYS | S&P 500 (SPY) |
|---|---|---|
| 1 month | -27.7% | -0.9% |
| 3 months | -30.6% | +2.1% |
| Year to date | -49.9% | +11.7% |
| 1 year | -55.8% | +12.4% |
| 3 years | +125.3% | +88.5% |
Key statistics
- Market value
- $1.50B
- 52-week range
- $18.18 to $47.33
- Next report
- Nov 4, 2026
About Mineralys Therapeutics
Develops therapeutic treatments for rare genetic diseases using gene therapy approaches.
Sector: Health Care
More on Mineralys Therapeutics
- Returns: what $1,000 became$1,000 three years ago is $2,253 today
No forecast, no recommendation. This page describes Mineralys Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.